[Vorinostat in the treatment of cutaneous T-cell lymphomas. Treatment with histone deacetylases inhibitors].
Zirlik
Katja
K
Abteilung Innere Medizin I, Medizinische Universitätsklinik, Hugstetter Strasse 55, D-79106 Freiburg i.Br.
Nashan
Dorothée
D
Veelken
Hendrik
H
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D009182:Mycosis Fungoides / Q000188:drug therapy; D012751:Sezary Syndrome / Q000188:drug therapy; D000077337:Vorinostat
D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D000077337:Vorinostat